Introduction {#sec1-1}
============

**What was known?**

Sarcoidosis is a systemic disease and the role of infectious microorganisms such as *Mycobacterium leprae* and *Leishmania infantum* in pathogenesis of sarcoidosis is investigated previously.There is no study on the role or presence of *Leishmania major*, which is endemic in Iran.

Sarcoidosis is a systemic disease characterized by non-caseating epithelioid granuloma formation that may affect almost any organ, including lungs, liver, lymph nodes, eyes, and skin.\[[@ref1]\] Several reports support the co-existence or even possible role of micro-organisms such as mycobacteria, especially cell-wall deficient forms like M. tuberculosis, atypical mycobacteria and M. leprae,\[[@ref2][@ref3][@ref4][@ref5][@ref6]\] *Rickettsia helvetica*,\[[@ref7]\] *Leishmania infantum*,\[[@ref8]\] and *Brucella melitensis*\[[@ref9]\] in development of sarcoidosis; However, the exact etiology of sarcoidosis still remains unknown.

Cutaneous leishmaniasis (CL), caused by various species of *Leishmania*, is a self-limited lesion which may rarely progress to complicated clinical forms; CL is the endemic disease of tropical and sub-tropical parts of the world and it is observed with high incidence in different parts of Iran.\[[@ref10][@ref11]\]

CL typically presents as a red, crusted nodule and is usually limited to the face or extremities. The chronic lesions of CL generally consists of tuberculoid granulomas with very few organisms in the upper half of dermis that often impinge on the epidermis. Occasionally, this chronic form presents with unusual clinical and histopathological features, which are not akin to stereotypical characteristics of leishmaniasis and may lead to misdiagnosis in some cases. In. other words, in endemic area a granuloma that is reported as sarcoidosis might be an atypical presentation of leishmaniasis and requires further investigation.

Polymerase Chain Reaction (PCR) can detect leishmaniasis genome with an acceptable sensitivity and specificity.\[[@ref12]\] We designed this study to investigate the association between sarcoid lesions and *Leishmania major* (*L. major*) by PCR technique in biopsy samples that were previously diagnosed as cutaneous sarcoidosis.

Materials and Methods {#sec1-2}
=====================

Sample collection {#sec2-1}
-----------------

The paraffin-embedded skin biopsy samples attained from cutaneous sarcoidosis patients referred between January 2001 and March 2009 were examined. The clinical impression of cutaneous sarcoidosis correlated with the histopathology diagnosis of naked sarcoidal type of granuloma in all cases. By investigating patients' files, the samples with positive Mantoux test and simulating causes were excluded. Sarcoidal type granuloma was defined as well demarcated islands of epithelioid cells, containing few giant cells and sparse lymphocytic infiltrations at the margins of the epithelioid cell granuloma; therefore the nomenclature naked granuloma. Applying conventional diagnostic methods, all samples had been evaluated for detection of fungal, bacterial or parasite microorganisms formerly. Among these studies were the ones utilizing special staining such as Hematoxylin-Eosin (H & E), Gram, Giemsa, Periodic Acid Schiff (PAS), Ziehl-Neelsen, modified Ziehl-Neelsen, and Grocott\'s Methenamine Silver. Nonetheless, all the results were negative; moreover, a second pathologist re-examined the specimens and re-confirmed the diagnosis of naked sarcoid type granuloma in each specimen.

For purpose of our study, all the specimens were investigated for *Leishmania* parasite by PCR technique. This phase was performed in the Molecular Biology Research Centre of SBMU and thereafter, was repeated by the Biotechnology Research Centre of Pasteur Institute, Tehran, Iran. All the results were confirmed by the second authority.

DNA isolation from paraffin-embedded tissue {#sec2-2}
-------------------------------------------

We performed DNA extraction from paraffin-embedded tissue samples according to High Yield DNA Purification kit\'s (DNPTM Kit, CinnaGen, Tehran, Iran) manual instructions. Paraffin tissue sections were cut with a microtome blade. For each sample, 2 ml of cleaning benzene followed by 3 ml of 2 M HCL were used to clean the microtome blade and all the other instruments. The samples were subsequently rinsed with 10 ml of sterile water. Thereafter, DNA isolation was performed according to DNPTM kit (Cinnagen, Tehran, Iran). Shortly after that, 500 μl of xylene was added to the tissue and in order to remove the paraffin, the specimen was incubated at room temperature for 30 minutes. The xylene was then discarded and the tissue was washed three times by 30 ml of water. Consequently, 500 μl of lysis buffer (0.33M sucrose, 20 mM Tris, 5 mM MgC12 and 2% SDS) was added to the reaction and the sample was incubated for two more hours at 37°C. Next we boiled it for 10 minutes. The samples were centrifuged at 4000 RPM for 5 minutes. Finally the supernatant was transferred to another tube and DNA was precipitated by employing 2 ml of 0.3 M sodium acetate and 1 ml of absolute ethanol; then it was centrifuged at 12000 g for 10 minutes. The obtained pellet was washed with 2 ml of 70% ethanol and was suspended in 50 ml distilled water.

PCR analysis {#sec2-3}
------------

Using specific molecular diagnostic kit from CinnaGen Co. (*Leishmania* sp. PCR Determination and Detection, CinnaGen, Tehran, Iran), we performed the PCR technique on the extracted DNA. This is PCR-based detection method developed using using parasite mitochondrial DNA (Kinetoplast DNA or K-DNA) as the target. 1 μl of the DNA was used in 50 μl reaction (1 μl Taq DNA polymerase, 5 μl of 10 × buffer, 2 μl of MgCl2, 2 μl of primers and 39μl of H2O). The PCR technique was carried out applying a step-up program as follows; initial denaturation for 3 minutes at 95°C, followed by 30 cycles at 94°C for 1 minute, 62°C for 1 minute, and 72°C for 1 minute, with a final extension of 7 minutes at 72°C. The negative control was PCR reaction without any DNA template. The positive control was provided in the kit. PCR product with 620bp band in 1.5% agarose gel electrophoresis is considered as *L. major*. In addition, PCR detection kit for Mycobacteria was obtained from CinnaGen Co, Tehran, Iran. Extracted DNA was used as template for detection of mycobacteria as instructed in the kit.

Results {#sec1-3}
=======

Thirty samples were examined and five were excluded: 3 due to positive Mantoux test and 2 due to inappropriateness of samples for analysis. Twenty-five paraffin-embedded blocks of skin biopsies were examined from patients with clinical diagnosis of cutaneous sarcoidosis and histopathology of naked granuloma in light microscopy \[[Figure 1](#F1){ref-type="fig"}\]; the samples were taken from 11 women and 14 men, ranging in age from 7 to 65, with a mean of 37.5 years.

![An asteroid body is shown within a multinucleated giant cell (Black arrow) (H and E, ×40)](IJD-59-316b-g001){#F1}

Clinical descriptions of lesions are demonstrated in [Table 1](#T1){ref-type="table"}. From histological point of view, no caseating necrosis was seen in these samples, but in one specimen fibrinoid or coagulation necrosis was observed; a fine reticulum network surrounded the granulomas in five cases. Moreover, no microorganism was observed in specimens stained with conventional and specific staining methods.

###### 

Description of skin lesions among all sarcoidal granuloma cases; along with their sex and age distribution

![](IJD-59-316b-g002)

However, in eight out of twenty-five cases, PCR analysis on paraffin-embedded tissues revealed an amplification band, 620-bp, compatible with *L. major* \[[Figure 2](#F2){ref-type="fig"}\]. As shown in the Figures [2a](#F2){ref-type="fig"}--[c](#F2){ref-type="fig"}, the positive control is a standard strain provided by World Health Organization as *L. major*/RU. The negative control is the PCR reaction without any DNA template to eliminate chances of any false positive contamination. One of the two samples in [Figure 2c](#F2){ref-type="fig"} (column 8) belongs to the skin biopsy of an individual who exhibited extra-cutaneous sarcoidosis. This patient had pulmonary involvement and coexistent diabetes mellitus. \[[Table 1](#T1){ref-type="table"}- case \#13\] Also in this patient, PCR results were positive for L. major in bronchoalveolar lavage (BAL) as well as his skin biopsy, which is shown in the other sample in [Figure 2c](#F2){ref-type="fig"} (column 7). One hypothesis holds mycobacterium tuberculosis responsible for this lesion. To rule out this possibility, the extracted DNA was amplified by MTB kit as defined in materials and methods section; however, only positive control of the kit was amplified. The sensitivity of the tests in this figures also demonstrates the fact that even with small amounts of DNA, we can obtain correct results due to the fact that k-DNA was employed as the amplification template.

![Agarose gel electrophoresis of PCR products from paraffin embedded samples. (a) 100 DNA ladder. Neg: Negative control A (No DNA template on the PCR reaction). Column \#1. PCR amplification of the paraffin embedded from patient number 4; Column \# 2. PCR amplification of the paraffin embedded from patient number 8; Column \# 3. PCR amplification of the paraffin embedded from patient number 19; Pos: PCR amplification of the *L. major* standard strain. (b) 100 DNA ladder. Neg: Negative control A (No DNA template on the PCR reaction). Column \# 4. PCR amplification of the paraffin embedded from patient number 14; Column \# 5. PCR amplification of the paraffin embedded from patient number 18. Column \# 6. PCR amplification of the paraffin embedded from patient number 20. (c) 100 DNA ladder. Neg: Negative control A (No DNA template on the PCR reaction). Column \# 7. PCR amplification of the paraffin embedded BAL sample from patient number 13. Column \# 8. PCR amplification of the paraffin embedded skin sample from patient number 13](IJD-59-316b-g003){#F2}

Discussion {#sec1-4}
==========

Sarcoidal granuloma (naked granuloma) may be found in a wide variety of diseases such as malignancies, local reaction to inert foreign substances and last but not least, infectious diseases; therefore, it should be always kept in mind that sarcoidosis is the diagnosis of exclusion.\[[@ref13]\] Nowadays and with the advent of modern microbiological techniques, a great number of cases that were previously considered as sarcoidosis are understood to be associated with different infectious diseases.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9]\] However, *Leishmania* genus has rarely been investigated in these conditions.\[[@ref8][@ref14][@ref15]\]

Among various clinical manifestations of cutaneous leishmaniasis, chronic forms represent a diagnostic dilemma either in clinical setting or from a histological aspect; in fact, it is challenging to distinguish it from other simulating infectious diseases such as tuberculoid leprosy, lupus vulgaris, lupoid rosacea and granuloma annulare. Several reports have described isolation of *Leishmania* spp. from a significant number of both single and multiple atypical nodular skin lesions.\[[@ref14][@ref16]\] From histological point of view, these granulomas, considered "naked" or "sarcoidal granuloma", are different from the classic tuberculoid granulomas observed in lupus vulgaris and chronic lupoid leishmaniasis, and normally would not be classified as granulomas caused by a living agent. Therefore, organism is either difficult to trace in those chronic lesions or is altogether absent. Until now, this feature has been reported frequently in association with various species of genus *Leishmania*.\[[@ref14][@ref16][@ref17]\] In actual practice, unusual forms of CL may be misinterpreted by some clinicians as sarcoidosis, particularly in cases where *Leishmania* amastigotes are not observed microscopically. Moreover, this insidious form has always misled physicians into misdiagnosing it as other mimicking diseases, whereas the treatment strategy in some (e.g., sarcoidosis) is in complete contradiction to leishmaniasis treatment.

Leishmaniasis is an opportunistic infection in immunocompromised patients. Mucosal and cutaneous leishmaniasis has been previously reported in patients undergoing transplantations and pulmonary tuberculosis.\[[@ref8]\] According to experimental studies in human CL, *Leishmania* infection is usually being controlled predominately by T-cell mediated mechanisms with a preferential Th1 pattern.\[[@ref18]\] The occurrence of CL in these immunodeficient patients, therefore, may be due to inadequate cellular response.

In our study, methotrexate, an immunosuppressive agent, which preferentially inhibits cellular immunity, was used in two patients, in whom the lesions were found to be diffuse. (Patients number 13 and 19 in [Table 1](#T1){ref-type="table"}.) Further investigations revealed pulmonary involvement in one of the latter two cases. These evidences provide strong support for the concept that CL (especially diffuse form) was more likely related to the immunosuppressive effects of methotrexate than to sarcoidosis itself. Furthermore, another remarkable outcome of our study is that despite various types of lesions, even diffuse ones, all extracted *Leishmania* organisms belonged to *L. major* species. To the best of our knowledge, the phenomenon of diffuse leishmaniasis due to *L. major* has not been reported yet.

Since its advent, PCR has been proven to be an accurate laboratory test for rapid detection of numerous antigenic agents (including infectious agents and *Leishmania* in particular). Safaei *et al*. reported 92% sensitivity and 100% specificity for PCR in the context of positive histology with granulomatous inflammation in cutaneous leishmaniasis. In a quasi-contrast, they also achieved a PCR positive result in 24 out of 29 cases where the histological diagnosis failed to identify amastigotes (82.7% sensitivity).\[[@ref12]\] In comparison with other diagnostic methods, sensitivity of PCR was higher and it has also been demonstrated that this discrepancy becomes more significant in chronic cases.\[[@ref18]\] The reason we employed K-DNA PCR, is its due to highest sensitivity among other PCR-based kits utilized for *Leishmania* detection such as Internal Transcribed Spacer 1 PCR (ITS1 PCR) and splice leader mini-exon PCR (SLME PCR). Additionally, in lesions where the likelihood of detection of micro-organism is low, kDNA PCR has also proved to be a more illuminating technique. This has been achieved because of high abundance of mini circles per parasite (\~10,000).\[[@ref19]\]

Leishmaniasis is a worldwide disease, although about 90% of cutaneous forms of *Leishmania* infection occur in seven countries including Iran.\[[@ref20]\] Based on several experiments, there are mainly two species of old-world *Leishmania* in this country, responsible for more than 90% of Iranian CL infection, including *L. major* and *L. tropica*.\[[@ref21][@ref22][@ref23]\] Thus, considering their endemicity, geographical distribution and epidemiological features, we investigated our samples utilizing these *Leishmania*-specific PCR fragments.

In conclusion, we recommend that in endemic areas, any granulomatous skin disease compatible with sarcoidal type granuloma (naked granuloma), regardless of its clinical presentation and even histological appearance should be further investigated by the aid of PCR for *Leishmania*-specific DNA.

**What is new?**

*Leishmania major* might be found in some cases of cutaneous sarcoidosisThere might be some association between *Leishmania major* and sarcoidosisPCR can be used to find the *Leishmania* species in patient with sarcoidosis in endemic area; the treatment of leishmaniasis may result in resolution of sarcoidosis lesions.
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